Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Li-Ming Gan

Professor/ chief physician

Li-Ming Gan
Professor/ chief physician
li-ming.gan@gu.se
+46 31 786 5387

Room number: 2152
Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Medicinaregatan 15 , 41390 Göteborg


Department of Molecular and Clinical Medicine at Institute of Medicine (More Information)
SU Sahlgrenska
413 45 Göteborg
Fax: +46 31823762
Visiting Address: Blå stråket 5 B Wallenberglab/SU , 413 45 Göteborg

Latest publications

Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo-controlled, phase I study in healthy volunteers
Li-Ming Gan, M. Lagerström-Fermér, H. Ericsson, K. Nelander, E. L. Lindstedt et al.
British Journal of Clinical Pharmacology, Journal article 2019
Journal article

SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob(-/-) mice
D. D. Adingupu, S. O. Gopel, J. Gronros, M. Behrendt, M. Sotak et al.
Cardiovascular Diabetology, Journal article 2019
Journal article

Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes
Li-Ming Gan, M. Lagerstrom-Fermer, L. G. Carlsson, C. Arfvidsson, A. C. Egnell et al.
Nature Communications, Journal article 2019
Journal article

Extracellular volume by cardiac magnetic resonance is associated with biomarkers of inflammation in hypertensive heart disease
J. A. Pan, E. Michaëlsson, P. W. Shaw, S. Kuruvilla, C. M. Kramer et al.
Journal of hypertension, Journal article 2019
Journal article

Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF
S. J. Shah, C. S. P. Lam, Sara Svedlund, A. Saraste, C. Hage et al.
European Heart Journal, Journal article 2018
Journal article

Showing 1 - 10 of 72

2019

Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo-controlled, phase I study in healthy volunteers
Li-Ming Gan, M. Lagerström-Fermér, H. Ericsson, K. Nelander, E. L. Lindstedt et al.
British Journal of Clinical Pharmacology, Journal article 2019
Journal article

SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob(-/-) mice
D. D. Adingupu, S. O. Gopel, J. Gronros, M. Behrendt, M. Sotak et al.
Cardiovascular Diabetology, Journal article 2019
Journal article

Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes
Li-Ming Gan, M. Lagerstrom-Fermer, L. G. Carlsson, C. Arfvidsson, A. C. Egnell et al.
Nature Communications, Journal article 2019
Journal article

Extracellular volume by cardiac magnetic resonance is associated with biomarkers of inflammation in hypertensive heart disease
J. A. Pan, E. Michaëlsson, P. W. Shaw, S. Kuruvilla, C. M. Kramer et al.
Journal of hypertension, Journal article 2019
Journal article

2018

Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF
S. J. Shah, C. S. P. Lam, Sara Svedlund, A. Saraste, C. Hage et al.
European Heart Journal, Journal article 2018
Journal article

2017

Showing 1 - 10 of 72

Page Manager: Karin Allander|Last update: 8/23/2019
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?